Beckman Coulter Buys Flow Cytometry Firm Blue Ocean Biomedical | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Beckman Coulter Life Sciences announced late Thursday it has acquired flow cytometry firm Blue Ocean Biomedical for an undisclosed amount.

According to Beckman Coulter, the deal provides it with low complexity analyzers that integrate automated sample preparation. It added the acquisition will allow it to directly address emerging flow cytometry market trends.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.